Penserra Capital Management LLC Omeros Corp Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$5.67 - $8.54 $8,108 - $12,212	-1,430 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.4 - $16.3 $134 - $163	10 Added 0.7%	1,430 $19,000
Q2 2021 Aug 12, 2021	BUY	$14.81 - $19.13 $444 - $573	30 Added 2.16%	1,420 $21,000
Q1 2021 May 13, 2021	SELL	$14.52 - $23.53 $363 - $588	-25 Reduced 1.77%	1,390 $24,000
Q4 2020 Feb 12, 2021	BUY	$10.14 - $15.19 $8,953 - $13,412	883 Added 165.98%	1,415 $20,000
Q3 2020 Nov 13, 2020	BUY	$9.57 - $21.32 $5,091 - $11,342	532 New	532 $5,000

124

25.7M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $557M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.